Myelodysplastic Syndromes + Aplastic Anaemia Flashcards
Clinical Features of Myelodysplastic Syndromes
BM failure and Cytopenias: infection, bleeding, fatigue
Hypercellular BM
Defective cells (RBC, WBC, Platelets) - expanded in later Q
How are RBC’s defective in Myelodysplastic Syndromes?
There is dyserythropoiesis of RBC: may see RING SIDEROBLASTS (abnormally nucleated blast surrounded by iron granule ring)
How are WBC’s defective in Myelodysplastic Syndromes?
Myelokathexis of neutrophils and precursors: hypogranulation, Pseudo-Pelger-Huet anomaly (bilobed/hyposegmented neutrophils)
How are platelets defective in Myelodysplastic Syndromes?
Dysplastic megakaryocytes with hypolobated nuclei, micromegakaryocytes
What are Myelodysplastic Syndromes?
A heterogenous group of progressive disorders featuring ineffective proliferation and differentiation of abnormally maturing myeloid stem cells.
Characterized by: peripheral cytopenia, qualitative abnormalities of cell maturation; risk of AML transformation
What age group do Myelodysplastic Syndromes typically affect and how quickly do symptoms develop?
Elderly; symptoms usually develop over weeks/months
What 3 factors contribute to the prognosis of Myelodysplastic Syndromes?
BM blast % (lower is better), karyotype, degree of cytopenia
What is the Mortality rule of 1/3 for Myelodysplastic Syndromes?
1/3 die from infection, 1/3 die from bleeding, 1/3 die from Acute Leukaemia
What percentage of patients with Myelodysplastic Syndromes develop Acute Myeloid Leukemia?
50%
When does a Myelodysplastic Syndrome become AML? (in relation to blast %)
> 20% blasts = AML
under 5% = normal
What are the treatments for Myelodysplastic Syndromes?
Supportive: transfusion, SPO, G CSF, ABx
Biological modifiers: immunosuppressive drugs, Lenalidomide, Azacytidine (hypomethylating agent)
Chemotherapy: Hydroxyurea/Carbamide, Cytarabine
Allogenic SCT (Stem Cell Therapy)
What are the subtypes of Myelodysplastic Syndromes, in order of progression? (May just be easier to look at the table on pg22 for this bit!)
Refractory Anaemia, Refractory Anaemia with Ringed Sideroblasts (RA +RS), Refractory Cytopenia with multilineage dysplasia (RCMD), RCMD + RS, Refractory Anaemia with excess blasts (RAEB I), RAEB II, RAEB III, MDS with 5q deletion, MDS Unclassified.
Blood and Bone Marrow features for Refractory Anaemia (RA)
Blood: Anaemia, no blasts
Bone Marrow: Erythroid dysplasia with less than 5% blasts
Blood and Bone Marrow features for Refractory Anaemia + Ringed Sideroblasts (RA + RS)
Blood: Anaemia, no blasts
Bone Marrow: Erythroid dysplasia with >15% ringed sideroblasts
Blood and Bone Marrow features for Refractory Cytopenia with multilineage dysplasia (RCMD)
Blood: Cytopenia in >= 2 cell lines
Bone Marrow: Dysplasia in > 10% cells in >= 2 cell lines